1.
GW25-e3180 Berberine attenuates cardiac dysfunction, fibrosis, inflammatory in diabetic cardiomyopathy
by Li, Guo-Hua
Journal of the American College of Cardiology, Oct 21, 2014, pp.C64-C65
2.
GW25-e4414 Berberine improves coronary vasodilation and prevents endothelial apoptosis via activating Akt-eNOS in diabetic rats
by Jiani, Li
Journal of the American College of Cardiology, Oct 21, 2014, Vol.64(16), p.C3
3.
GW26-e1240 CD226 Molecule Associated with Type 2 Diabetes Mellitus via Modulating Glucose Uptake in Endothelial Cells under Hyperglycemic Conditions
by Zhang, Yuan
Journal of the American College of Cardiology, Oct 20, 2015, Vol.66(16), p.C22
4.
Prognostic influence of metformin as first‐line chemotherapy for advanced nonsmall cell lung cancer in patients with type 2 diabetes
by Tan, Ben‐Xu
Cancer, 15 November 2011, Vol.117(22), pp.5103-5111
5.
GW29-e1772 Circulating mir-122-5p: a novel vascular self-protection mechanism in type 2 diabetes
by Wu, Jie
Journal of the American College of Cardiology, Oct 16, 2018, Vol.72(16), p.C58
6.
Upregulation of caveolin-1 contributes to aggravated high-salt diet-induced endothelial dysfunction and hypertension in type 1 diabetic rats
by Li, Xu
Life Sciences, 15 September 2014, Vol.113(1-2), pp.31-39
7.
Meta-Analysis of Impact of Diabetes Mellitus on Outcomes After Transcatheter Aortic Valve Implantation.
by Sun, Yinghao
The American journal of cardiology, February 15, 2017, Vol.119(4), pp.623-629
8.
Hepatic artery vs. portal vein infusion of microbeads: a large animal pre-clinical model evaluating the intrahepatic capacity for cell infusion and imaging.
by Wang, Wei
Xenotransplantation, 2010 May-Jun, Vol.17(3), pp.207-214
9.
Peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α) enhances engraftment and angiogenesis of mesenchymal stem cells in diabetic hindlimb ischemia.
by Lu, Debin
Diabetes, May 2012, Vol.61(5), pp.1153-1159
10.
GW28-e0988 Berberine attenuates cardiac fibrosis via downregulating IGF1R in diabetic rats
by Li, Guohua
Journal of the American College of Cardiology, Oct 17, 2017, p.C38
11.
12.
A possible mechanism linking hyperglycemia and reduced high-density lipoprotein cholesterol levels in diabetes
by Gao, Feng
Journal of Huazhong University of Science and Technology [Medical Sciences], 2010, Vol.30(3), pp.318-321
13.
Impaired mitochondrial biogenesis due to dysfunctional adiponectin-AMPK-PGC-1α signaling contributing to increased vulnerability in diabetic heart
by Yan, Wenjun
Basic Research in Cardiology, 2013, Vol.108(3), pp.1-15
14.
Exome sequencing identifies novel ApoB loss-of-function mutations causing hypobetalipoproteinemia in type 1 diabetes
by Gao, Feng
Acta Diabetologica, 2015, Vol.52(3), pp.531-537
15.
GSK256073 acutely regulates NEFA levels via HCA2 agonism but does not achieve durable glycaemic control in type 2 diabetes. A randomised trial
by Dobbins, Robert
European Journal of Pharmacology, 15 May 2015, Vol.755, pp.95-101
16.
A reduction in both visceral and subcutaneous fats contributes to increased adiponectin by lifestyle intervention in the Diabetes Prevention Program.
by Zhang, Chao
Acta diabetologica, June 2015, Vol.52(3), pp.625-628
17.
Functional genetic variants within the SIRT2 gene promoter in acute myocardial infarction
by Yang, Wentao
PLoS One, Apr 2017, p.e0176245
18.
Berberine reduces ischemia/reperfusion-induced myocardial apoptosis via activating AMPK and PI3K-Akt signaling in diabetic rats.
by Chen, Keke
Apoptosis : an international journal on programmed cell death, June 2014, Vol.19(6), pp.946-957
19.
Type 2 diabetes mitigation in the diabetic Goto–Kakizaki rat by elevated bile acids following a common-bile-duct surgery
by Gao, Feng
Metabolism, February 2016, Vol.65(2), pp.78-88
20.
Mechanisms for food polyphenols to ameliorate insulin resistance and endothelial dysfunction: therapeutic implications for diabetes and its cardiovascular complications
by Munir, Kashif
American Journal of Physiology, Sep 15, 2013, p.E679
